Alimera Sciences to Report Third Quarter 2023 Financial Results on October 26, 2023, and Provide Corporate Update
16 Outubro 2023 - 9:00AM
Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global
pharmaceutical company whose mission is to be invaluable to
patients, physicians and partners concerned with retinal health and
maintaining better vision longer, announces today that it will
report third quarter financial results on October 26, 2023, prior
to the market open.
Management will host a conference call at 9:00 AM ET on the same
day, to review financial results and provide an update on corporate
developments. Following management’s formal remarks there will be a
question-and-answer session.
Participants can register for the conference by navigating
to https://dpregister.com/sreg/10183110/fa99503540
Please note that registered participants will receive their
dial-in number upon registration and will dial directly into the
call without delay. Those without Internet access or who are unable
to pre-register may dial in by calling 1-844-839-2190 (domestic) or
1-412-717-9583 (international). All callers should dial in
approximately 10 minutes prior to the scheduled start time and ask
to be joined into the Alimera Sciences call.
The conference call will also be available through live webcast
at https://event.choruscall.com/mediaframe/webcast.html?webcastid=8U00zjTjAnd
is also available through the company’s website.
A webcast replay of the call will be available approximately one
hour after the end of the call through January 26, 2024. The
webcast replay can be accessed through the above links or by
calling 1-877-344-7529 (domestic) or 1-412-317-0088 (international)
and using access code #4883233. The telephonic replay will be
available until November 9, 2023.
About Alimera Sciences, Inc. Alimera Sciences a
global pharmaceutical company whose mission is to be invaluable to
patients, physicians and partners concerned with retinal health and
maintaining better vision longer. For more information, please
visit www.alimerasciences.com.
For press inquiries:Jules Abrahamfor Alimera
Sciences917-885-7378julesa@coreir.com |
For investor inquiries:Scott Gordonfor Alimera
Sciencesscottg@coreir.com |
Alimera Sciences (NASDAQ:ALIM)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Alimera Sciences (NASDAQ:ALIM)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024